Skip to main content
. 2014 May 8;16(8):1094–1103. doi: 10.1093/ntr/ntu036

Table 2.

Verified 7-Day Point Prevalence and Continuous Abstinence Rates

Assessment timepoint 7-day point prevalence Continuous abstinence
AE (n = 30) HEC (n = 31) OR (95% CI) AE (n = 30) HEC (n = 31) OR (95% CI)
End of treatment (8 weeks postquit date) 40.0% 22.6% 2.28 (0.75, 6.96) 30.0% 25.8% 1.23 (0.4, 3.78)
6-month follow-up (21 weeks postquit date) 26.7% 12.9% 2.46 (0.65, 9.26) 23.3% 9.7% 2.83 (0.66, 12.18)
12-month follow-up (47 weeks postquit date) 26.7% 12.9% 2.46 (0.65, 9.26) 13.3% 3.2% 4.64 (0.48, 44.5)

Note. AE = aerobic exercise; HEC = health education control; OR = odds ratio; CI = confidence interval.